Who is the ozmpic component added to the list of essential drugs
The World Health Organization has added GLP-1 drugs to treat diabetes to the treatment of cystic fibrosis and cancer as well as its essential medicines, and said it hopes that it will help improve global access to expensive drugs.
ListConsisting from 523 drugs for adults and 374 for children, there is a list of drugs that believe that all working should be available in health systems. In the past, including a drug, has helped promote access to people in poor countries, such as HIV treatment in the early 2000s.
The head of WHO Secretariat, Dr. Lorenzo Moja said, “Instead of allowing the price to be an unqualified factor, the committee includes a potential catalyst to join the list of necessary drugs.”
Expert Committee added to the list of active materials in the ozmpic of Novo Nordisk and Elli Lily’s selections, which to treat type 2 diabetes in combination with installed heart disease, chronic kidney disease or obesity.
In January 2026, the Canadian patent for ozmpic will end, will pave the way for cheap generic versions of semaglutide injections that help regulate blood sugar levels and appetite. Medical Director of BC Diabetes, Dr. Tom Elliot says that Semaglutide injection has revolutionized their practice, and they are surprisingly effective.
The drugs were initially developed for diabetes, but under individual brand names, wild-popular weight-drugs have also become drugs, but the WHO reduced them by adding them to the treatment of obesity alone, as also done in 2023.
The committee said that this decision provided clear guidance, on which patients will benefit the most from the remedies.
The WHO’s statement said, “High prices of drugs such as semaglutide and tirzepetide are limiting access to these drugs,” WHO’s statement stated that encouraging generic drug manufacturers to produce products will also help when patents begin to end on drugs next year.
A spokesman for Novo Nordisk said that the company was committed to supporting widespread access to its treatments.
Many companies are already working on normal copies.
Globally, more than 800 million people worldwide lived with diabetes in 2022, the WHO said. There are more than one billion people with obese. Earlier this year, WHO Memo stated that it would recommend the use of drugs for obesity, a different step to add them to the required list.
Cancer, Cystic fibrosis who list the therapy
The list also includes a combination therapy of vertex pharmaceutical for cystic fibrosis, tricefta or kaftrio. The activists have criticized its high price and lack of access to years.
SickTrikafta: Healing is not always simple
They say that there is the only stable change in life, but what happens when the change you have been given feels like a two -edged sword? In this episode, the boys sit with the Koni, a young woman whose life with cystic fibrosis has taken a sharp turn to Trichfta. She shares the raw realities of navigating a new chapter where her body, mind and future are all in flow. From the wave effects of this life-changing drug to the unpredictable burden of the years, the Koni investigates the challenges of re-defining itself and looking for the community in a world that suddenly feels more expected and isolated. Hold the full video version of this episode on YouTube (https://www.youtube.com/channel/ucstejcbe9-zvg7nxgf- jwbg)! Instagram (https://www.instagram.com/sickboypodcast), tiktok (https://www.tiktok.com/@sickboypodcast) and discord (https://discord.gg/expePEudn).
It also includes the treatment of merc top-celling cancer immunotherapy drugs, kitruda, cervical cancer, colorectal cancer and non-types of lung cancer, which are spread to increase access, or are metastasized, and strategies are recommended.
The WHO also added rapid-acting insulin analogs, which Novo Nordisk and Elli Lily have also made a list for the treatment of type 1, type 2 and pregnancy diabetes among others.
